- Home
- ERAS vs PHK Comparison
ERAS vs PHK Comparison
Compare ERAS & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- PHK
- Stock Information
- Founded
- ERAS 2018
- PHK 2003
- Country
- ERAS United States
- PHK United States
- Employees
- ERAS N/A
- PHK N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- PHK Finance/Investors Services
- Sector
- ERAS Health Care
- PHK Finance
- Exchange
- ERAS Nasdaq
- PHK Nasdaq
- Market Cap
- ERAS 719.0M
- PHK 777.7M
- IPO Year
- ERAS 2021
- PHK N/A
- Fundamental
- Price
- ERAS $2.67
- PHK $4.89
- Analyst Decision
- ERAS Strong Buy
- PHK
- Analyst Count
- ERAS 5
- PHK 0
- Target Price
- ERAS $6.10
- PHK N/A
- AVG Volume (30 Days)
- ERAS 1.7M
- PHK 491.5K
- Earning Date
- ERAS 11-12-2024
- PHK 01-01-0001
- Dividend Yield
- ERAS N/A
- PHK 12.61%
- EPS Growth
- ERAS N/A
- PHK N/A
- EPS
- ERAS N/A
- PHK N/A
- Revenue
- ERAS N/A
- PHK N/A
- Revenue This Year
- ERAS N/A
- PHK N/A
- Revenue Next Year
- ERAS N/A
- PHK N/A
- P/E Ratio
- ERAS N/A
- PHK N/A
- Revenue Growth
- ERAS N/A
- PHK N/A
- 52 Week Low
- ERAS $1.51
- PHK $4.13
- 52 Week High
- ERAS $3.45
- PHK $5.15
- Technical
- Relative Strength Index (RSI)
- ERAS 43.56
- PHK 30.11
- Support Level
- ERAS $2.59
- PHK $4.97
- Resistance Level
- ERAS $3.19
- PHK $5.10
- Average True Range (ATR)
- ERAS 0.20
- PHK 0.04
- MACD
- ERAS -0.02
- PHK -0.02
- Stochastic Oscillator
- ERAS 20.13
- PHK 6.52
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.